Comparison of Nutritional Information With Iron-succinate Supplementation in Healthy Women
Launched by UNIVERSITY HOSPITAL, LINKOEPING · Oct 11, 2024
Trial Information
Current as of November 05, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study is looking at how two different ways to boost iron affect iron levels in the blood of menstruating, healthy women who regularly exercise. Participants are randomly assigned to one of two groups for 8 weeks: (1) follow written guidance to eat more iron-rich foods, or (2) take a daily 100 mg iron-succinate pill. The main thing researchers will measure is changes in ferritin, a blood marker that shows iron stores in the body. They will also look at other blood measures related to blood health and wellbeing.
Who can join? Women aged 20–40 who are menstruating, healthy, and regularly exercise. You must be able to complete online questionnaires. Exclusion includes significant diseases that affect inflammation or blood levels, or difficulty filling out forms. The study is being run in Sweden at Linköping University Hospital. If you participate, you’ll have blood tests and height/weight checked at the start and after 8 weeks, answer online questions, and you’ll receive 2000 SEK for the blood draw at the end. The trial is currently enrolling by invitation, and results are not yet available.
Gender
FEMALE
Eligibility criteria
- • Inclusion Criteria: Inclusion criteria will be menstruating women aged 20 to 40 years who are healthy and regularly exercise.
- • -
- • Exclusion Criteria: Significant disease affecting inflammation and/or hemoglobin levels. Inability to cooperate or to fill out questionnaires.
- • -
About University Hospital, Linkoeping
The University Hospital in Linköping is a leading academic medical center renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pivotal institution within the region, it integrates cutting-edge medical practices with academic excellence, facilitating a collaborative environment for healthcare professionals and researchers. The hospital actively participates in a wide range of clinical trials across various medical disciplines, aiming to enhance patient outcomes and contribute to the global body of medical knowledge. With a focus on ethical standards and patient safety, the University Hospital in Linköping is dedicated to pioneering solutions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Linköping, Sweden
Patients applied
Trial Officials
Fredrik H Nyström, MD PhD Professor
Principal Investigator
Linkoeping University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported